- Home
- QSI vs AUTL Comparison
QSI vs AUTL Comparison
Compare QSI & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- AUTL
- Stock Information
- Founded
- QSI 2013
- AUTL 2014
- Country
- QSI United States
- AUTL United Kingdom
- Employees
- QSI N/A
- AUTL N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QSI Health Care
- AUTL Health Care
- Exchange
- QSI Nasdaq
- AUTL Nasdaq
- Market Cap
- QSI 226.8M
- AUTL 625.4M
- IPO Year
- QSI N/A
- AUTL 2018
- Fundamental
- Price
- QSI $1.62
- AUTL $1.32
- Analyst Decision
- QSI Strong Buy
- AUTL Strong Buy
- Analyst Count
- QSI 3
- AUTL 5
- Target Price
- QSI $2.38
- AUTL $9.12
- AVG Volume (30 Days)
- QSI 5.6M
- AUTL 4.4M
- Earning Date
- QSI 11-11-2025
- AUTL 11-11-2025
- Dividend Yield
- QSI N/A
- AUTL N/A
- EPS Growth
- QSI N/A
- AUTL N/A
- EPS
- QSI N/A
- AUTL N/A
- Revenue
- QSI $3,412,000.00
- AUTL $29,934,000.00
- Revenue This Year
- QSI N/A
- AUTL $641.63
- Revenue Next Year
- QSI $219.33
- AUTL $109.21
- P/E Ratio
- QSI N/A
- AUTL N/A
- Revenue Growth
- QSI 100.47
- AUTL 185.17
- 52 Week Low
- QSI $0.61
- AUTL $1.11
- 52 Week High
- QSI $5.77
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- QSI 70.59
- AUTL 29.07
- Support Level
- QSI $1.24
- AUTL $1.26
- Resistance Level
- QSI $1.16
- AUTL $1.46
- Average True Range (ATR)
- QSI 0.10
- AUTL 0.09
- MACD
- QSI 0.06
- AUTL 0.01
- Stochastic Oscillator
- QSI 97.50
- AUTL 16.77
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.